See all newsFDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASEJanuary 7, 2023View News Article Categories: Advancements in Alzheimer's disease